ARKG Investment Tracker

Source from:official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·03-01 07:13
      ARKG Investment Tracker position change: Increased position in Amgen by 1,900 shares, the number of shares held increased 4.59% compared to the previous period and now represents 1.24% of the total position.
      501Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·03-01 07:13
      ARKG Investment Tracker position change: Increased position in 10x Genomics, Inc. by 149,264 shares, the number of shares held increased 4.59% compared to the previous period and now represents 5.71% of the total position.
      375Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·03-01 07:13
      ARKG Investment Tracker position change: Increased position in Guardant Health Inc. by 25,118 shares, the number of shares held increased 4.59% compared to the previous period and now represents 4.25% of the total position.
      220Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·03-01 07:13
      ARKG Investment Tracker position change: Increased position in Incyte by 6,156 shares, the number of shares held increased 4.58% compared to the previous period and now represents 1.07% of the total position.
      190Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·03-01 07:13
      ARKG Investment Tracker position change: Increased position in CareDx by 143,206 shares, the number of shares held increased 6.59% compared to the previous period and now represents 3.31% of the total position.
      106Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·03-01 07:13
      ARKG Investment Tracker position change: Increased position in Veeva by 266 shares, the number of shares held increased 4.34% compared to the previous period and now represents 0.089% of the total position.
      92Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·03-01 07:13
      ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 505,742 shares, the number of shares held increased 4.59% compared to the previous period and now represents 1.56% of the total position.
      20.15K1
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·03-01 07:13
      ARKG Investment Tracker position change: Increased position in Adaptive Biotechnologies Corp by 97,546 shares, the number of shares held increased 4.59% compared to the previous period and now represents 2.77% of the total position.
      5.33K1
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·03-01 07:13
      ARKG Investment Tracker position change: Increased position in Twist Bioscience Corp by 95,304 shares, the number of shares held increased 4.59% compared to the previous period and now represents 8.02% of the total position.
      429Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·03-01 07:13
      ARKG Investment Tracker position change: Increased position in Beam Therapeutics, Inc. by 102,030 shares, the number of shares held increased 4.59% compared to the previous period and now represents 5.1% of the total position.
      241Comment
      Report
     
     
     
     

    Most Discussed